Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Clover Corporation Limited ( (AU:CLV) ) has provided an announcement.
Clover Corporation Limited announced a change in the director’s interest, specifically involving Peter Davey. The change reflects an increase in the number of performance rights held directly by the director, with 529,638 performance rights acquired and 255,199 disposed of, resulting in a total of 1,361,706 performance rights held. This adjustment in holdings may indicate strategic positioning or confidence in the company’s future performance, potentially impacting stakeholders’ perceptions and the company’s market positioning.
The most recent analyst rating on (AU:CLV) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
More about Clover Corporation Limited
Clover Corporation Limited operates in the health and nutrition industry, focusing on the development and supply of high-quality ingredients and products. The company is known for its innovative solutions in the field of nutritional oils, which are used in various applications including infant formula, pharmaceuticals, and food products.
Average Trading Volume: 165,226
Technical Sentiment Signal: Hold
Current Market Cap: A$112.7M
For an in-depth examination of CLV stock, go to TipRanks’ Overview page.

